Every year, cancer affects millions of people throughout the world. Despite significant advances in medicine, there are still many difficulties that need to be addressed in order to enhance cancer treatment. At the transition stage of cancer when it shifts from a localized to a systemic form of disease with metastases, systemic cancer treatments are required. Systemic cancer treatment can be either prophylactic (for example, post-surgery) or therapeutic. The present cancer research scenario is diverse with ample opportunities for constant therapeutic improvement that consider not just patient recovery but also their well-being during treatment. Radiomics, immunotherapy, and exosomes are the three entries that have grown the most in the past decade.
Important Alert:
X
Title : Deubiquitylase USP31 induces autophagy and promotes the progression in lung squamous cell carcinoma cells by stabilizing E2F1 expression
Qian Zhang, The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, China
Title :
Luca Roncati, University of Modena and Reggio Emilia, Italy
Title :
Bene Ekine-Afolabi, ZEAB Therapeutic Ltd, United Kingdom
Title :
K.P.Mishra, Asian Association for Radiation Research, India